What is dehydroepiandrosterone (DHEA) and what are its effects and potential benefits in women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

What is DHEA and What Does It Do for Women?

DHEA (dehydroepiandrosterone) is a steroid hormone precursor produced primarily by the adrenal glands that converts to testosterone and estrogen in peripheral tissues, but systemic DHEA supplementation is not recommended for postmenopausal women with normal adrenal function because it does not significantly improve libido, sexual function, or quality of life. 1

What DHEA Is

DHEA is one of the main precursors of androgens (male hormones) that are subsequently converted to both testosterone and estrogen in the body. 2 It is primarily synthesized in the adrenal cortex, with some additional production in peripheral tissues. 2 DHEA levels naturally peak in the second and third decades of life and then progressively decline with age—a phenomenon termed "adrenopause"—independent of menopausal status. 3

The adrenal gland is the major source of DHEA and its sulfate form (DHEAS) in women, not the ovaries. 4 This distinguishes it from ovarian androgens, which are suppressed by conditions like hypogonadism or oral contraceptive use. 4

Evidence-Based Indications for DHEA in Women

Where DHEA May Have Limited Benefit

  • Adrenal insufficiency (primary or secondary): Women with adrenal insufficiency have reduced DHEAS levels. 4 A 2009 meta-analysis found that DHEA therapy may result in small improvements in health-related quality of life and depression, but had no effects on anxiety or sexual well-being. 4 One small study (n=24) showed increased frequency of sexual thoughts and improved well-being, but overall evidence remains insufficient to support routine use. 4, 3

  • Anorexia nervosa: DHEA levels after ACTH stimulation were not lower in women with anorexia nervosa compared to controls, suggesting hypogonadotropic hypogonadism—not adrenal androgen deficiency—is the primary issue. 4 Studies using DHEA 50 mg daily for bone health showed maintenance of bone mineral density but no significant increases. 4

Where DHEA Shows Benefit

  • Vulvovaginal atrophy (intravaginal use): Intravaginal DHEA administration improves symptoms of vaginal atrophy including dyspareunia, burning, itching, and dryness. 5 Objective parameters (pH, vaginal maturation index, epithelial integrity) also improved compared to baseline and placebo. 5 This local application appears effective and safer than systemic estrogen therapy, especially for women with estrogen sensitivity. 2

Where DHEA Does NOT Work

  • Postmenopausal women with normal adrenal function: Systemic DHEA is not associated with significant improvement in libido or sexual function and cannot be recommended for hypoactive sexual desire disorder (HSDD). 1 This is a Level IA, Grade A recommendation—the highest quality evidence. 1

  • General menopausal symptoms: A 2015 Cochrane review of 28 trials (1,273 women) found no evidence that DHEA improves quality of life compared to placebo. 6 Results for menopausal symptoms were inconsistent and could not be pooled due to measurement heterogeneity. 6

  • Sexual function (oral use): While the Cochrane review found a small improvement in sexual function (SMD 0.31), this effect was modest and of questionable clinical significance. 6 The 2019 global consensus statement firmly recommends against systemic DHEA for HSDD. 1

Safety Profile and Adverse Effects

  • Androgenic side effects: DHEA is associated with a nearly 4-fold increased risk of androgenic side effects, mainly acne (OR 3.77,95% CI 1.36-10.4). 6

  • Long-term safety unknown: Risks of high physiologic or pharmacologic DHEA use include androgenic and estrogenic side effects, which are concerning for long-term administration. 3

  • No serious adverse effects reported: Current evidence suggests DHEA supplementation has not been associated with serious adverse effects in clinical trials. 7

Clinical Pitfalls to Avoid

  • Do not use DHEA routinely in healthy postmenopausal women. The evidence is clear that it does not improve quality of life, menopausal symptoms, or sexual function in women with normal adrenal function. 1, 6

  • Distinguish between systemic and intravaginal use. Intravaginal DHEA has demonstrated efficacy for vulvovaginal atrophy, while systemic (oral) DHEA has not shown consistent benefits. 1, 5

  • Avoid compounded "bioidentical" DHEA products. These cannot be recommended due to lack of evidence for efficacy and safety, unless an authorized equivalent preparation is not available. 1

  • Do not confuse DHEA with testosterone therapy. While both are androgens, testosterone has specific indications for HSDD in postmenopausal women (with appropriate monitoring), whereas systemic DHEA does not. 1

  • Recognize DHEA-deficient states. The only populations where DHEA may have modest benefit are women with documented adrenal insufficiency, not healthy women experiencing age-related DHEA decline. 4, 3

References

1
Guideline

global consensus position statement on the use of testosterone therapy for women.

The Journal of clinical endocrinology and metabolism, 2019

3
Research

Should Dehydroepiandrosterone Be Administered to Women?

The Journal of clinical endocrinology and metabolism, 2022

4
Guideline

androgen therapy in women: a reappraisal: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2014

6
Research

Dehydroepiandrosterone for women in the peri- or postmenopausal phase.

The Cochrane database of systematic reviews, 2015

Related Questions

How should elevated dehydroepiandrosterone (DHEA) be evaluated and managed in an adult?
What is the appropriate dosage and usage of Prasterone (dehydroepiandrosterone (DHEA)) for a postmenopausal woman with moderate to severe menopause symptoms or for a patient with adrenal insufficiency?
What are the effects of 25mg Dehydroepiandrosterone (DHEA) on a perimenopausal or menopausal woman in her 40s?
What is the recommended dosing regimen, application sites, duration of use, and contraindications for a 1% DHEA topical cream in an adult patient who is not pregnant, not nursing, and has no history of hormone‑sensitive cancer or uncontrolled endocrine disease?
What is the normal reference range for serum unconjugated dehydroepiandrosterone (DHEA) in a 44-year-old premenopausal woman?
Is there any indication to assess serum testosterone levels in an 84‑year‑old male?
How can I manage excessive sleepiness in a patient taking Abilify (aripiprazole)?
Can bupropion (Wellbutrin) be used to treat fatigue associated with depression, and what is the appropriate dosing and monitoring?
In a patient with serum vitamin B12 of 252 pg/mL (borderline) and markedly elevated serum folate >23.9 ng/mL, should vitamin B12 replacement be initiated despite normal thyroid function (TSH 2.4 uU/mL) and vitamin D level (45.6 ng/mL)?
Which empiric antibiotics should be initiated for septic arthritis, and should colchicine be added when administering an intra‑articular corticosteroid injection for a gout flare?
What is the maximum daily dose of Tylenol (acetaminophen) with codeine for a healthy adult?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.